Dr. Sinclair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 E. State Street
Suite 301
Media, PA 19063Phone+1 610-892-1708Fax+1 610-892-8766
Summary
- I am a board certified ophthalmologist specializing in surgical and medical treatment of vitreoretinal diseases.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Surgical Retina and Vitreous, 1978 - 1979
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1975 - 1977
- Massachusetts General HospitalInternship, Transitional Year, 1973 - 1974
- Harvard Medical SchoolClass of 1973
- Trinity CollegeMS, Biophysics, 1968 - 1969
- University of PennsylvaniaB.A., 1964 - 1968
Certifications & Licensure
- UT State Medical License 2019 - 2024
- PA State Medical License 1979 - 2021
- NJ State Medical License 1991 - 1995
- WI State Medical License 1978 - 1978
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Ecumenical Hospitaler Order Knights of St John of Malta 2012
- Senior Achievement Award American Academy of Ophthalmology, 2001
- Honor Award for Education American Academy of Ophthalmology, 1985
- Join now to see all
Publications & Presentations
Journal Articles
- ERK- and AKT-dependent neuroprotection of erythropoietin (Epo) against glyoxa-AGES via modulation of BCL-xL, Bax, and BADShen,J, Wu,Y, Xu,JY, Zhang, J, Sinclair,SH, Xu,G, Yanoff,M, Li, Y, Xu, G, IOVS, 1/1/2010
- Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular EdemaLi, W., S. Sinclair, GT. Xu, Ophthal Lasers, Imaging & Surgery, 1/1/2010
- Screening Down athletes for ocular diseaseGutstein, W, Sinclair, SH, North, R., Bekiroglu, N, Optometry- Journal of the American Optometric Association, 1/1/2010
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Evaluation of Monocular Neutral Density and Yellow Filters on Reading by Patients with Symptomatic Monocular MetamorphopsiaStephen H. Sinclair; Maryana Kravchenko, ARVO, 1/1/2012
- Evaluation of Nuclear Cataract and Straylight on Central Vision Measured with the Central Vision Analyzer (CVA)Stephen H. Sinclair; Walter Gutstein, Rachel V. North, ARVO, 1/1/2012
- Intravitreal Procrit in Eyes with Non-Proliferative Diabetic Retinaopathy and Diffuse Macular EdemaStephen H. Sinclair; Li, Weiye; Presti, Peter, EVRS, 1/1/2011
- Join now to see all
Lectures
- Intravitreal Procrit in Eyes with Geographic Atrophy Secondary to ARMD Contiguous Grid Micropulse Laser for Diffuse Resistant Macular Edema associated with Diabetic Re...Cap Cana, DR - 2/28/2012
- Micropulse Laser Treatment of Diabetic Macular EdemaMalta - 9/30/2011
- Intravitreal Procrit in Eyes with Non-Proliferative Diabetic Retinopathy and Diffuse Macular Edema9/5/2011
- Join now to see all
Authored Content
- Should High Contrast Chart Acuity Continue to Be Used as a Functional Outcome for Clinical Trials of Macular Disease?August 2020
- Diabetic Retinopathy as a Predictor of Systemic Micro and Macrovascular ComplicationsAugust 2020
- Innovations to Assist in Pre-Retinal Membrane SurgeryAugust 2020
- Should High Contrast Chart Acuity Continue to Be Used as a Functional Outcome for Clinical Trials of Macular Disease?August 2020
- Diabetic Retinopathy as a Predictor of Systemic Micro and Macrovascular ComplicationsAugust 2020
- Innovations to Assist in Pre-Retinal Membrane SurgeryAugust 2020
- Join now to see all
Grant Support
- Blue Field Entoptic Test &Macular CirculationNational Eye Institute1987–1989
- Blue Field Entoptic Test &Macular CirculationNational Eye Institute1987
- Blue Field Entopic Test And Macular CirculationNational Eye Institute1985
Research History
- ConsultantMicrosoft Research- Accessibilities2019 - Present
- Sinclair TechnologiesPlease see website www.sinclairtechnologies.com2015 - Present
Professional Memberships
- Fellow
- Member
Industry Relationships
- Consultant, Molecular Targeting Technologies, PSVueDevelopment of retinal targeting technologies2019 - Present
- CMO, GSX PharmaDevelopment of ophthalmic natriceuticals, oral screening assist program2015 - Present
- Board of Medical Advisors, InjectSenseDevelops miniaturized intraocular 24 x 7 pressure and other signals2015 - Present
- CEO, Sinclair TechnologiesMultiple diagnostic devices developed and brought through FDA approval, multiple drugs in processDisclosure: Multiple diagnostic devices2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: